Hiroki Nakata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hiroki Nakata has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Atsushi Mizokami
Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
9 shared publicationsShoichi Iseki
Department of Clinical Engineering Faculty of Health Sciences Komatsu University Komatsu Japan
9 shared publications- Atsushi Mizokami
Department of Integrative Cancer Therapy and Urology Kanazawa University Graduate School of Medical Science Kanazawa Ishikawa Japan
8 shared publications - Kazuyoshi Shigehara
Department of Integrative Cancer Therapy and Urology Kanazawa University Graduate School of Medical Science Kanazawa Ishikawa Japan
8 shared publications - Kouji Izumi
Department of Integrative Cancer Therapy and Urology Kanazawa University Graduate School of Medical Science Kanazawa Ishikawa Japan
8 shared publications - Shohei Kawaguchi
Department of Urology, NHO Kanazawa Medical Center, Kanazawa, Japan, Japan
5 shared publications
Latest Publications
- Open Access
- 5 November 2026
- Published by MDPI AG in Preprints.org
Anatomical Distribution of Human Papillomavirus Infection in the Lower Urinary Tract of Men with Bladder Cancer Undergoing Radical Cystectomy
We investigated the anatomical distribution of human papillomavirus (HPV) infection in the lower urinary tract of men with bladder cancer undergoing radical cystectomy. In total, 79 anterior urethral samples, 99 prostatic urethral specimens, 74 bladder tumor specimens, and 87 non-tumor bladder specimens were collected from 102 patients. After DNA extraction from each formalin-fixed paraffin-embedded tissue specimen, HPV-DNA was examined by nested polymerase chain reaction, and HPV genotypes were determined by Sanger sequencing. In situ hybridization (ISH) was used to localize HPV-DNA in positive samples, and E6/E7 mRNA ISH was performed to assess transcriptional activity. HPV-DNA was detected at any site in 16 (15.7%) of 102 patients, with site-specific detection rates of 8.0% (7/87) in non-tumor bladder mucosa, 5.1% (4/79) in the anterior urethra, 4.1% (3/74) in bladder tumor tissue, and 4.0% (4/99) in the prostatic urethra. HPV16 was detected in 11 samples, and HPV18 in 7 samples. HPV-DNA ISH signals were observed in 12 (66.7%) of 18 HPV-positive specimens, and E6/E7 mRNA signals were present in 2 of 18 specimens. HPV-DNA was detected at various sites of the lower urinary tract. E6/E7 mRNA expression in a bladder cancer specimen warrants further research on the biological relevance of HR-HPV infection.
- 5 November 2026
- Published by MDPI AG in Preprints.org
Open AccessAnatomical Distribution of Human Papillomavirus Infection in the Lower Urinary Tract of Men with Bladder Cancer Undergoing Radical Cystectomy
We investigated the anatomical distribution of human papillomavirus (HPV) infection in the lower urinary tract of men with bladder cancer undergoing radical cystectomy. In total, 79 anterior urethral samples, 99 prostatic urethral specimens, 74 bladder tumor specimens, and 87 non-tumor bladder specimens were collected from 102 patients. After DNA extraction from each formalin-fixed paraffin-embedded tissue specimen, HPV-DNA was examined by nested polymerase chain reaction, and HPV genotypes were determined by Sanger sequencing. In situ hybridization (ISH) was used to localize HPV-DNA in positive samples, and E6/E7 mRNA ISH was performed to assess transcriptional activity. HPV-DNA was detected at any site in 16 (15.7%) of 102 patients, with site-specific detection rates of 8.0% (7/87) in non-tumor bladder mucosa, 5.1% (4/79) in the anterior urethra, 4.1% (3/74) in bladder tumor tissue, and 4.0% (4/99) in the prostatic urethra. HPV16 was detected in 11 samples, and HPV18 in 7 samples. HPV-DNA ISH signals were observed in 12 (66.7%) of 18 HPV-positive specimens, and E6/E7 mRNA signals were present in 2 of 18 specimens. HPV-DNA was detected at various sites of the lower urinary tract. E6/E7 mRNA expression in a bladder cancer specimen warrants further research on the biological relevance of HR-HPV infection.
- Open Access
- 5 November 2026
- Published by MDPI AG in Preprints.org
Human Papillomavirus Prevalence in Seminal Tract Among the Patients with Testicular Tumor; Dose HPV Infection Have an Etiological Role for the Development of Testicular Tumor?
This study investigated the prevalence, genotypes, and tissue localization of human papillomavirus (HPV)-DNA in testicular tumor including epididymis and spermatic cord specimens from 116 Japanese patients who underwent radical inguinal orchiectomy. Formalin-fixed, paraffin-embedded tissues were analyzed by nested polymerase chain reaction (PCR), followed by sequencing-based HPV genotyping. HPV-DNA localization was assessed by in situ hybridization (ISH), and E6/E7 mRNA ISH was performed in HPV-positive specimens. HPV-DNA was detected in three patients (3/116, 2.6%), including one testicular tumor specimen (1/116, 0.9%) and two spermatic cord specimens (2/116, 1.7%). All HPV-positive specimens contained HPV16-DNA. HPV-DNA ISH signals were observed in seminoma cells in one testicular specimen and in the vas deferens epithelium in one spermatic cord specimen. On the other hand, ISH signals were not present in epididymis tissue in the HPV-positive testicular tumor tissue, suggesting that HPV-DNA detection rate of epididymis was 0%. E6/E7 mRNA signals were not detected in any HPV-positive specimen. These findings demonstrate that HPV16-DNA was surely present in testicular tumor and the vas deferens epithelium. However we could not provide evidence of transcriptionally active HPV oncogenes, and could not establish a causal role in testicular tumorigenesis.
- 5 November 2026
- Published by MDPI AG in Preprints.org
Open AccessHuman Papillomavirus Prevalence in Seminal Tract Among the Patients with Testicular Tumor; Dose HPV Infection Have an Etiological Role for the Development of Testicular Tumor?
This study investigated the prevalence, genotypes, and tissue localization of human papillomavirus (HPV)-DNA in testicular tumor including epididymis and spermatic cord specimens from 116 Japanese patients who underwent radical inguinal orchiectomy. Formalin-fixed, paraffin-embedded tissues were analyzed by nested polymerase chain reaction (PCR), followed by sequencing-based HPV genotyping. HPV-DNA localization was assessed by in situ hybridization (ISH), and E6/E7 mRNA ISH was performed in HPV-positive specimens. HPV-DNA was detected in three patients (3/116, 2.6%), including one testicular tumor specimen (1/116, 0.9%) and two spermatic cord specimens (2/116, 1.7%). All HPV-positive specimens contained HPV16-DNA. HPV-DNA ISH signals were observed in seminoma cells in one testicular specimen and in the vas deferens epithelium in one spermatic cord specimen. On the other hand, ISH signals were not present in epididymis tissue in the HPV-positive testicular tumor tissue, suggesting that HPV-DNA detection rate of epididymis was 0%. E6/E7 mRNA signals were not detected in any HPV-positive specimen. These findings demonstrate that HPV16-DNA was surely present in testicular tumor and the vas deferens epithelium. However we could not provide evidence of transcriptionally active HPV oncogenes, and could not establish a causal role in testicular tumorigenesis.
- Open Access
- 28 October 2026
- Published by Springer Nature in Scientific Reports
Spatially heterogeneous restoration of spermatogenesis in the mouse testis following experimental cryptorchidism and orchidopexy
Spermatogenesis is a highly temperature-sensitive process that occurs within the testis and is rapidly impaired upon exposure to abdominal heat. Although spermatogenesis may recover once heat stress is relieved, it remains unclear whether this restoration occurs uniformly within the three-dimensional architecture of the testis. In the present study, we combined experimental cryptorchidism and orchidopexy in adult mice with deep learning-based whole-organ three-dimensional reconstruction. Following 8 weeks of cryptorchidism, markedly impaired segments accounted for 94% of the total tubule length. Ten weeks after orchidopexy, although 87% of the tubule length returned to a normal state, the remaining impaired segments were preferentially located near the rete testis and immediately beneath the tunica albuginea. In the cryptorchid testis, type A spermatogonia were not reduced beneath the tunica albuginea. Incomplete restoration beneath the tunica albuginea was not detected in the vitamin A-deficient testis after the switch to a vitamin A-containing diet. These results suggest that the incomplete restoration beneath the tunica albuginea arises after orchidopexy and may be specific to cryptorchidism. This knowledge may help optimize sperm retrieval, although verification in the human testis is required.
- 28 October 2026
- Published by Springer Nature in Scientific Reports
Open AccessSpatially heterogeneous restoration of spermatogenesis in the mouse testis following experimental cryptorchidism and orchidopexy
Spermatogenesis is a highly temperature-sensitive process that occurs within the testis and is rapidly impaired upon exposure to abdominal heat. Although spermatogenesis may recover once heat stress is relieved, it remains unclear whether this restoration occurs uniformly within the three-dimensional architecture of the testis. In the present study, we combined experimental cryptorchidism and orchidopexy in adult mice with deep learning-based whole-organ three-dimensional reconstruction. Following 8 weeks of cryptorchidism, markedly impaired segments accounted for 94% of the total tubule length. Ten weeks after orchidopexy, although 87% of the tubule length returned to a normal state, the remaining impaired segments were preferentially located near the rete testis and immediately beneath the tunica albuginea. In the cryptorchid testis, type A spermatogonia were not reduced beneath the tunica albuginea. Incomplete restoration beneath the tunica albuginea was not detected in the vitamin A-deficient testis after the switch to a vitamin A-containing diet. These results suggest that the incomplete restoration beneath the tunica albuginea arises after orchidopexy and may be specific to cryptorchidism. This knowledge may help optimize sperm retrieval, although verification in the human testis is required.
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Early On‑Treatment Peripheral T-Cell Receptor Repertoire Remodeling Predicts Survival in Immune Checkpoint Inhibitor-Treated Urothelial and Renal Cell Carcinoma
Reliable early biomarkers of immune checkpoint inhibitor (ICI) efficacy remain limited in urothelial carcinoma (UC) and renal cell carcinoma (RCC). Because ICIs reshape tumor-reactive T-cell populations, early peripheral T-cell receptor (TCR) repertoire changes may provide treatment-informed prognostic information. We analyzed peripheral blood samples from 70 patients with UC or RCC treated with anti–PD-1/PD-L1 therapy, collected at baseline and 3–4 weeks after treatment initiation. TCRα and TCRβ repertoires were profiled using adaptor-ligation PCR and deep sequencing. Repertoire diversity was quantified using the Shannon index, and changes from baseline were calculated. Associations with progression-free survival, cancer-specific survival, and overall survival were assessed using Cox regression and Kaplan–Meier analyses. Pretreatment TCR diversity did not stratify clinical outcomes. In contrast, higher posttreatment TCRα diversity was associated with improved cancer-specific and overall survival, while increased TCRα diversity from baseline further stratified overall survival. A four-quadrant classification integrating posttreatment TCRα diversity and its early change showed clear separation of overall survival curves, with patients in the High–High group having the most favorable prognosis. TCRβ-based metrics showed weaker but directionally similar associations. These findings suggest that early on-treatment remodeling of the peripheral TCRα repertoire, particularly higher posttreatment diversity and greater increases from baseline, may serve as a minimally invasive biomarker for long-term survival in patients receiving ICI therapy.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessEarly On‑Treatment Peripheral T-Cell Receptor Repertoire Remodeling Predicts Survival in Immune Checkpoint Inhibitor-Treated Urothelial and Renal Cell Carcinoma
Reliable early biomarkers of immune checkpoint inhibitor (ICI) efficacy remain limited in urothelial carcinoma (UC) and renal cell carcinoma (RCC). Because ICIs reshape tumor-reactive T-cell populations, early peripheral T-cell receptor (TCR) repertoire changes may provide treatment-informed prognostic information. We analyzed peripheral blood samples from 70 patients with UC or RCC treated with anti–PD-1/PD-L1 therapy, collected at baseline and 3–4 weeks after treatment initiation. TCRα and TCRβ repertoires were profiled using adaptor-ligation PCR and deep sequencing. Repertoire diversity was quantified using the Shannon index, and changes from baseline were calculated. Associations with progression-free survival, cancer-specific survival, and overall survival were assessed using Cox regression and Kaplan–Meier analyses. Pretreatment TCR diversity did not stratify clinical outcomes. In contrast, higher posttreatment TCRα diversity was associated with improved cancer-specific and overall survival, while increased TCRα diversity from baseline further stratified overall survival. A four-quadrant classification integrating posttreatment TCRα diversity and its early change showed clear separation of overall survival curves, with patients in the High–High group having the most favorable prognosis. TCRβ-based metrics showed weaker but directionally similar associations. These findings suggest that early on-treatment remodeling of the peripheral TCRα repertoire, particularly higher posttreatment diversity and greater increases from baseline, may serve as a minimally invasive biomarker for long-term survival in patients receiving ICI therapy.
Spatially Heterogeneous Impairment of Spermatogenesis in the Testis Following Efferent Duct Transection in Mice
Background: Obstructive azoospermia, with a sustained elevation in intratesticular pressure, leads to seminiferous epithelium degeneration. However, studies using efferent duct ligation have not fully elucidated the chronic changes in the testis caused by obstruction. Objective: Using the efferent duct transection model, we aimed to elucidate the temporal and spatial progression of spermatogenic impairment in the mouse testis. Materials and Methods: Male mice underwent efferent duct transection and were analyzed at five time points up to 20 weeks. A three‐dimensional reconstruction of serial testis sections was employed to visualize and quantitate impaired spermatogenesis in the seminiferous tubules. Results: The volumes of the testis, seminiferous tubules, and interstitium showed 2–3‐fold increases 1 week post‐transection, but normalized by 5 weeks. The volume of the rete testis continued to increase, and was 9.3‐fold larger by 20 weeks. The impairment of spermatogenesis in the seminiferous epithelium was progressive until 20 weeks. Three‐dimensional mapping revealed marked spatial heterogeneity in impaired spermatogenesis: cranial seminiferous tubules remained highly viable, while the majority of caudal tubules were impaired. Furthermore, areas of severe impairment were identified in tubule regions near the rete testis in all tubules. Discussion and Conclusions: The present results suggest that chronic obstructive stress, driven by mechanical stress and/or local ischemia, is dominant in the caudal region and near the rete testis of the mouse testis. This study established a crucial link between obstructive azoospermia and a pathology resembling non‐obstructive azoospermia, underscoring the importance of evaluating such spatial vulnerability in the clinical management of obstructive male infertility.
Spatially Heterogeneous Impairment of Spermatogenesis in the Testis Following Efferent Duct Transection in Mice
Background: Obstructive azoospermia, with a sustained elevation in intratesticular pressure, leads to seminiferous epithelium degeneration. However, studies using efferent duct ligation have not fully elucidated the chronic changes in the testis caused by obstruction. Objective: Using the efferent duct transection model, we aimed to elucidate the temporal and spatial progression of spermatogenic impairment in the mouse testis. Materials and Methods: Male mice underwent efferent duct transection and were analyzed at five time points up to 20 weeks. A three‐dimensional reconstruction of serial testis sections was employed to visualize and quantitate impaired spermatogenesis in the seminiferous tubules. Results: The volumes of the testis, seminiferous tubules, and interstitium showed 2–3‐fold increases 1 week post‐transection, but normalized by 5 weeks. The volume of the rete testis continued to increase, and was 9.3‐fold larger by 20 weeks. The impairment of spermatogenesis in the seminiferous epithelium was progressive until 20 weeks. Three‐dimensional mapping revealed marked spatial heterogeneity in impaired spermatogenesis: cranial seminiferous tubules remained highly viable, while the majority of caudal tubules were impaired. Furthermore, areas of severe impairment were identified in tubule regions near the rete testis in all tubules. Discussion and Conclusions: The present results suggest that chronic obstructive stress, driven by mechanical stress and/or local ischemia, is dominant in the caudal region and near the rete testis of the mouse testis. This study established a crucial link between obstructive azoospermia and a pathology resembling non‐obstructive azoospermia, underscoring the importance of evaluating such spatial vulnerability in the clinical management of obstructive male infertility.
- Open Access
Human Papillomavirus Prevalence in the Prostate and Seminal Vesicles: Does This Virus Have an Etiological Role in the Development of Prostate Cancer?
Human papillomavirus (HPV) is common in both sexes and is also detected in male urine and semen. However, its exact origin and its etiological role in the male genital tract remain unclear. A total of 157 formalin-fixed paraffin-embedded tissues from 156 primary prostate cancer lesions and one metastatic lesion were analyzed. HPV-DNA was detected using a nested PCR, and HPV genotyping was performed using flow-through hybridization for positive cases. In situ hybridization (ISH) was used to localize HPV-DNA, whereas HPV-E6/E7 mRNA ISH and p16INK4a immunohistochemistry were conducted on high-risk (HR) HPV-positive samples. A nested PCR analysis demonstrated that HPV-DNA was detected in 9.6% of prostate cancers and 0% of seminal vesicles. HR-HPV was observed in 4.5% of the samples. Unknown type was the most common genotype. Of the genotypes which could be identified in the genotyping assay, HPV44 was the most prevalent. HPV prevalence was significantly higher in patients with high-grade groups. Among 15 HPV-positive cases, HPV-DNA was found in 9 cancerous and 10 non-cancerous lesions. E6/E7 mRNA was expressed in 6 of 7 HR-HPV-positive cases, while p16INK4a expression was weak or absent in all cases. HPV can infect prostate tissue and may contribute to carcinogenesis in some cases, but p16INK4a was not a consistent surrogate for E7 expression.
Open AccessHuman Papillomavirus Prevalence in the Prostate and Seminal Vesicles: Does This Virus Have an Etiological Role in the Development of Prostate Cancer?
Human papillomavirus (HPV) is common in both sexes and is also detected in male urine and semen. However, its exact origin and its etiological role in the male genital tract remain unclear. A total of 157 formalin-fixed paraffin-embedded tissues from 156 primary prostate cancer lesions and one metastatic lesion were analyzed. HPV-DNA was detected using a nested PCR, and HPV genotyping was performed using flow-through hybridization for positive cases. In situ hybridization (ISH) was used to localize HPV-DNA, whereas HPV-E6/E7 mRNA ISH and p16INK4a immunohistochemistry were conducted on high-risk (HR) HPV-positive samples. A nested PCR analysis demonstrated that HPV-DNA was detected in 9.6% of prostate cancers and 0% of seminal vesicles. HR-HPV was observed in 4.5% of the samples. Unknown type was the most common genotype. Of the genotypes which could be identified in the genotyping assay, HPV44 was the most prevalent. HPV prevalence was significantly higher in patients with high-grade groups. Among 15 HPV-positive cases, HPV-DNA was found in 9 cancerous and 10 non-cancerous lesions. E6/E7 mRNA was expressed in 6 of 7 HR-HPV-positive cases, while p16INK4a expression was weak or absent in all cases. HPV can infect prostate tissue and may contribute to carcinogenesis in some cases, but p16INK4a was not a consistent surrogate for E7 expression.
- Open Access
- 11 August 2025
- Published by MDPI AG in Preprints.org
Human Papillomavirus Prevalence in the Prostate and Seminal Vesicles: Does This Virus Have an Etiological Role in the Development of Prostate Cancer?
Human papillomavirus (HPV) is common in both sexes and is also detected in male urine and semen. However, its exact origin and its etiological role in the male genital tract remain unclear. Formalin-fixed paraffin-embedded tissues from 157 prostate cancer patients were analyzed. HPV-DNA was detected using a nested PCR reaction, and HPV genotyping was performed using flow-through hybridization for positive cases. In situ hybridization (ISH) was used to localize HPV-DNA, whereas HPV-E6/E7 mRNA ISH and p16INK4a immunohistochemistry were conducted on high-risk (HR) HPV-positive samples. HPV-DNA was detected in 9.6% of prostate cancers and 0% of seminal vesicles. HR-HPV was observed in 4.5% of the samples, with HPV44 being the most common genotype. HPV prevalence was significantly higher in patients with high-grade groups (GG 4–5). Among 15 HPV-positive cases, HPV-DNA was found in 9 cancerous and 10 non-cancerous lesions. E6/E7 mRNA was expressed in 6 of 7 HR-HPV-positive cases, while p16INK4a expression was weak or absent in all cases. HPV can infect prostate tissue and may contribute to carcinogenesis in some cases, but p16INK4a may not be a consistent surrogate for E7 expression.
- 11 August 2025
- Published by MDPI AG in Preprints.org
Open AccessHuman Papillomavirus Prevalence in the Prostate and Seminal Vesicles: Does This Virus Have an Etiological Role in the Development of Prostate Cancer?
Human papillomavirus (HPV) is common in both sexes and is also detected in male urine and semen. However, its exact origin and its etiological role in the male genital tract remain unclear. Formalin-fixed paraffin-embedded tissues from 157 prostate cancer patients were analyzed. HPV-DNA was detected using a nested PCR reaction, and HPV genotyping was performed using flow-through hybridization for positive cases. In situ hybridization (ISH) was used to localize HPV-DNA, whereas HPV-E6/E7 mRNA ISH and p16INK4a immunohistochemistry were conducted on high-risk (HR) HPV-positive samples. HPV-DNA was detected in 9.6% of prostate cancers and 0% of seminal vesicles. HR-HPV was observed in 4.5% of the samples, with HPV44 being the most common genotype. HPV prevalence was significantly higher in patients with high-grade groups (GG 4–5). Among 15 HPV-positive cases, HPV-DNA was found in 9 cancerous and 10 non-cancerous lesions. E6/E7 mRNA was expressed in 6 of 7 HR-HPV-positive cases, while p16INK4a expression was weak or absent in all cases. HPV can infect prostate tissue and may contribute to carcinogenesis in some cases, but p16INK4a may not be a consistent surrogate for E7 expression.
- 2 June 2025
- Published by Wiley in Journal of Anatomy
- Vol. 247 (6) , 1204-1214
Three‐dimensional analysis of seminiferous tubules and spermatogenesis in the musk shrew, Suncus murinus
We reconstructed in three dimensions all seminiferous tubules in the testes of 1‐ and 8‐week‐old musk shrews ( Suncus murinus ), a small experimental mammal belonging to the family Soricidae, order Eulipotyphla that preserves the primitive characteristics of mammalian species. Quantitative analyses revealed that the basic structure of seminiferous tubules at 1 week postpartum remained consistent into adulthood. A single dominant seminiferous tubule with extensive branching accounted for more than 90% of the length of all tubules, a feature distinct from that in mice and rats. Pachytene spermatocytes were observed in the seminiferous epithelia of most tubules at 1 week, which was markedly earlier than in mice and rats. At 8 weeks, a mosaic pattern of active and inactive areas of spermatogenesis was observed through the length of seminiferous tubules, a feature distinct from that in mice and rats. The percentage of active areas was significantly lower in tubule portions near the rete testis. The unique characteristics of seminiferous tubules in the musk shrew will provide a basis for investigating not only the phylogeny of testis functions but also the regulation of spermatogenesis and possibly the pathogenesis of azoospermia.
- 2 June 2025
- Published by Wiley in Journal of Anatomy
- Vol. 247 (6) , 1204-1214
Three‐dimensional analysis of seminiferous tubules and spermatogenesis in the musk shrew, Suncus murinus
We reconstructed in three dimensions all seminiferous tubules in the testes of 1‐ and 8‐week‐old musk shrews ( Suncus murinus ), a small experimental mammal belonging to the family Soricidae, order Eulipotyphla that preserves the primitive characteristics of mammalian species. Quantitative analyses revealed that the basic structure of seminiferous tubules at 1 week postpartum remained consistent into adulthood. A single dominant seminiferous tubule with extensive branching accounted for more than 90% of the length of all tubules, a feature distinct from that in mice and rats. Pachytene spermatocytes were observed in the seminiferous epithelia of most tubules at 1 week, which was markedly earlier than in mice and rats. At 8 weeks, a mosaic pattern of active and inactive areas of spermatogenesis was observed through the length of seminiferous tubules, a feature distinct from that in mice and rats. The percentage of active areas was significantly lower in tubule portions near the rete testis. The unique characteristics of seminiferous tubules in the musk shrew will provide a basis for investigating not only the phylogeny of testis functions but also the regulation of spermatogenesis and possibly the pathogenesis of azoospermia.
- Open Access
Molecular Mechanisms and Therapeutic Potential of Mulberry Fruit Extract in High-Fat Diet-Induced Male Reproductive Dysfunction: A Comprehensive Review
High-fat diet (HFD)-induced obesity represents a significant challenge to male reproductive health, affecting approximately 13% of the global adult population. This comprehensive review synthesizes current evidence regarding mulberry (Morus alba L.) fruit extract’s therapeutic potential for HFD-induced male reproductive dysfunction. Through comprehensive analysis of the peer-reviewed literature from multiple databases (PubMed, Web of Science, Scopus, and Google Scholar; 2005–2024), we evaluated mulberry extract’s effects on testicular morphology, spermatogenesis, sperm parameters, and the underlying molecular mechanisms. Mechanistic studies reveal that standardized mulberry extract mediates protective effects through multiple pathways: enhanced antioxidant enzyme activities (SOD: +45%, Catalase: +38%, GPx: +35%), reduced inflammatory markers (TNF-α: −64%, IL-6: −58%), and modulated NF-κB signaling (−42.3%). These effects are facilitated by mulberry’s rich phytochemical profile, particularly anthocyanins (2.92–5.35 mg/g dry weight) and polyphenols (4.23–6.38 mg/g). The extract demonstrates particular efficacy in preserving seminiferous tubule integrity and maintaining blood-testis barrier function, with treated groups maintaining up to 85% of normal tubular architecture compared to HFD controls. Key molecular mechanisms include AMPK/SIRT1 pathway activation (2.3-fold increase), enhanced mitochondrial function (67% increase in mtDNA copy number), and epigenetic regulation of metabolic pathways. Temporal analysis indicates optimal therapeutic effects after 28 days of treatment, with initial improvements observable within 14 days. While current evidence is promising, limitations include predominant reliance on rodent models and lack of standardized extraction protocols. Future research priorities include well-designed human clinical trials, standardization of preparation methods, and investigation of potential synergistic effects with other therapeutic agents. This comprehensive review indicates that mulberry extract is a promising therapeutic candidate for obesity-related male infertility, warranting further clinical investigation.
Open AccessMolecular Mechanisms and Therapeutic Potential of Mulberry Fruit Extract in High-Fat Diet-Induced Male Reproductive Dysfunction: A Comprehensive Review
High-fat diet (HFD)-induced obesity represents a significant challenge to male reproductive health, affecting approximately 13% of the global adult population. This comprehensive review synthesizes current evidence regarding mulberry (Morus alba L.) fruit extract’s therapeutic potential for HFD-induced male reproductive dysfunction. Through comprehensive analysis of the peer-reviewed literature from multiple databases (PubMed, Web of Science, Scopus, and Google Scholar; 2005–2024), we evaluated mulberry extract’s effects on testicular morphology, spermatogenesis, sperm parameters, and the underlying molecular mechanisms. Mechanistic studies reveal that standardized mulberry extract mediates protective effects through multiple pathways: enhanced antioxidant enzyme activities (SOD: +45%, Catalase: +38%, GPx: +35%), reduced inflammatory markers (TNF-α: −64%, IL-6: −58%), and modulated NF-κB signaling (−42.3%). These effects are facilitated by mulberry’s rich phytochemical profile, particularly anthocyanins (2.92–5.35 mg/g dry weight) and polyphenols (4.23–6.38 mg/g). The extract demonstrates particular efficacy in preserving seminiferous tubule integrity and maintaining blood-testis barrier function, with treated groups maintaining up to 85% of normal tubular architecture compared to HFD controls. Key molecular mechanisms include AMPK/SIRT1 pathway activation (2.3-fold increase), enhanced mitochondrial function (67% increase in mtDNA copy number), and epigenetic regulation of metabolic pathways. Temporal analysis indicates optimal therapeutic effects after 28 days of treatment, with initial improvements observable within 14 days. While current evidence is promising, limitations include predominant reliance on rodent models and lack of standardized extraction protocols. Future research priorities include well-designed human clinical trials, standardization of preparation methods, and investigation of potential synergistic effects with other therapeutic agents. This comprehensive review indicates that mulberry extract is a promising therapeutic candidate for obesity-related male infertility, warranting further clinical investigation.
- Open Access
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis